11/6
08:10 am
biib
Biogen (NASDAQ:BIIB) was upgraded by analysts at Stifel Nicolaus from a "hold" rating to a "buy" rating. They now have a $202.00 price target on the stock, up previously from $144.00.
Low
Report
Biogen (NASDAQ:BIIB) was upgraded by analysts at Stifel Nicolaus from a "hold" rating to a "buy" rating. They now have a $202.00 price target on the stock, up previously from $144.00.
11/6
08:10 am
biib
Biogen (NASDAQ:BIIB) was upgraded by analysts at Stifel Nicolaus from a "hold" rating to a "buy" rating. They now have a $202.00 price target on the stock, up previously from $144.00.
Low
Report
Biogen (NASDAQ:BIIB) was upgraded by analysts at Stifel Nicolaus from a "hold" rating to a "buy" rating. They now have a $202.00 price target on the stock, up previously from $144.00.
11/6
07:44 am
biib
Rating for BIIB
Low
Report
Rating for BIIB
11/6
05:17 am
biib
Biogen upgraded to Buy from Hold at Stifel
Low
Report
Biogen upgraded to Buy from Hold at Stifel
11/3
07:47 am
biib
Rating for BIIB
Low
Report
Rating for BIIB
11/3
07:47 am
biib
Rating for BIIB
Low
Report
Rating for BIIB
10/31
10:32 am
biib
Rating for BIIB
Low
Report
Rating for BIIB
10/31
10:32 am
biib
Rating for BIIB
Low
Report
Rating for BIIB
10/10
01:35 pm
biib
Rating for BIIB
Low
Report
Rating for BIIB
10/10
01:35 pm
biib
Rating for BIIB
Low
Report
Rating for BIIB
9/25
06:59 am
biib
Rating for BIIB
Low
Report
Rating for BIIB
9/25
06:59 am
biib
Rating for BIIB
Low
Report
Rating for BIIB
9/24
09:17 pm
biib
Biogen initiated with a Buy at Jefferies
Low
Report
Biogen initiated with a Buy at Jefferies
9/24
09:17 pm
biib
Biogen initiated with a Buy at Jefferies
Low
Report
Biogen initiated with a Buy at Jefferies
9/24
10:31 am
biib
Biogen (NASDAQ:BIIB) had its "outperform" rating reaffirmed by analysts at William Blair.
Low
Report
Biogen (NASDAQ:BIIB) had its "outperform" rating reaffirmed by analysts at William Blair.
9/24
10:31 am
biib
Biogen (NASDAQ:BIIB) had its "outperform" rating reaffirmed by analysts at William Blair.
Low
Report
Biogen (NASDAQ:BIIB) had its "outperform" rating reaffirmed by analysts at William Blair.
9/24
10:12 am
biib
Biogen (NASDAQ:BIIB) had its "neutral" rating reaffirmed by analysts at Citigroup Inc..
Low
Report
Biogen (NASDAQ:BIIB) had its "neutral" rating reaffirmed by analysts at Citigroup Inc..
9/24
08:07 am
biib
Biogen (NASDAQ:BIIB) had its "hold" rating reaffirmed by analysts at Needham & Company LLC.
Low
Report
Biogen (NASDAQ:BIIB) had its "hold" rating reaffirmed by analysts at Needham & Company LLC.
9/24
06:09 am
biib
Rating for BIIB
Low
Report
Rating for BIIB
9/24
06:09 am
biib
Rating for BIIB
Low
Report
Rating for BIIB